Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence of primary hepatitis C infection among people who inject drugs during 2012-2020 in Athens, Greece.
Roussos S, Bagos C, Angelopoulos T, Chaikalis S, Cholongitas E, Savvanis S, Papadopoulos N, Kapatais A, Chounta A, Ioannidou P, Deutsch M, Manolakopoulos S, Sevastianos V, Papageorgiou MV, Vlachogiannakos I, Mela M, Elefsiniotis I, Vrakas S, Karagiannakis D, Pliarchopoulou F, Psichogiou M, Paraskevis D, Vickerman P, Malliori M, Kalamitsis G, Papatheodoridis G, Hatzakis A, Sypsa V. Roussos S, et al. Among authors: angelopoulos t. J Viral Hepat. 2024 May 14. doi: 10.1111/jvh.13951. Online ahead of print. J Viral Hepat. 2024. PMID: 38742938
The Sociodemographic Factors Related to Disability of Applicants of Welfare Benefits in Greece: A Cross-Sectional Survey Based on the World Health Organization Disability Assessment Schedule (WHODAS) 2.0.
Theotokatos G, Escorpizo R, Angelopoulos TJ, Chrysagis NK, Venieri A, Bickenbach J, Karteroliotis K, Grammatopoulou E, Skordilis E. Theotokatos G, et al. Among authors: angelopoulos tj. Cureus. 2024 Mar 6;16(3):e55614. doi: 10.7759/cureus.55614. eCollection 2024 Mar. Cureus. 2024. PMID: 38586637 Free PMC article.
High levels of all-cause mortality among people who inject drugs from 2018 to 2022.
Roussos S, Angelopoulos T, Cholongitas E, Savvanis S, Papadopoulos N, Kapatais A, Chounta A, Ioannidou P, Deutsch M, Manolakopoulos S, Sevastianos V, Papageorgiou MV, Vlachogiannakos I, Mela M, Elefsiniotis I, Vrakas S, Karagiannakis D, Pliarchopoulou F, Chaikalis S, Tsirogianni E, Psichogiou M, Kalamitsis G, Leobilla F, Paraskevis D, Malliori M, Goulis I, Papatheodoridis G, Hatzakis A, Sypsa V. Roussos S, et al. Among authors: angelopoulos t. Int J Drug Policy. 2024 Apr;126:104356. doi: 10.1016/j.drugpo.2024.104356. Epub 2024 Feb 23. Int J Drug Policy. 2024. PMID: 38394950
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Psychometric Properties of the 12-Item World Health Organization Disability Assessment Schedule (WHODAS 2.0), Greek Version: A Cross-Sectional Study on Applicants of Welfare Benefits.
Theotokatos G, Escorpizo R, Angelopoulos TJ, Chrysagis NK, Bickenbach J, Venieri A, Karteroliotis K, Grammatopoulou E, Skordilis E. Theotokatos G, et al. Among authors: angelopoulos tj. Cureus. 2023 Nov 9;15(11):e48588. doi: 10.7759/cureus.48588. eCollection 2023 Nov. Cureus. 2023. PMID: 38084177 Free PMC article.
103 results